These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28380373)

  • 1. Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway.
    Kubota T; Kubota N; Kadowaki T
    Cell Metab; 2017 Apr; 25(4):797-810. PubMed ID: 28380373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin.
    Besse-Patin A; Jeromson S; Levesque-Damphousse P; Secco B; Laplante M; Estall JL
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4285-4290. PubMed ID: 30770439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting type 2 diabetes: lessons from a knockout model of insulin receptor substrate 2.
    Oliveira JM; Rebuffat SA; Gasa R; Gomis R
    Can J Physiol Pharmacol; 2014 Aug; 92(8):613-20. PubMed ID: 24977713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent Roles of IRS (Insulin Receptor Substrate) 1 and 2 in Liver and Skeletal Muscle.
    Eckstein SS; Weigert C; Lehmann R
    Curr Med Chem; 2017; 24(17):1827-1852. PubMed ID: 28462703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity.
    Kubota N; Kubota T; Kajiwara E; Iwamura T; Kumagai H; Watanabe T; Inoue M; Takamoto I; Sasako T; Kumagai K; Kohjima M; Nakamuta M; Moroi M; Sugi K; Noda T; Terauchi Y; Ueki K; Kadowaki T
    Nat Commun; 2016 Oct; 7():12977. PubMed ID: 27708333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.
    Hotamisligil GS; Budavari A; Murray D; Spiegelman BM
    J Clin Invest; 1994 Oct; 94(4):1543-9. PubMed ID: 7523453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UPS in diabetes and obesity.
    Wing SS
    BMC Biochem; 2008 Oct; 9 Suppl 1(Suppl 1):S6. PubMed ID: 19007436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes.
    Lin X; Taguchi A; Park S; Kushner JA; Li F; Li Y; White MF
    J Clin Invest; 2004 Oct; 114(7):908-16. PubMed ID: 15467829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dehydroepiandrosterone (DHEA) on Akt and protein kinase C zeta (PKCζ) phosphorylation in different tissues of C57BL6, insulin receptor substrate (IRS)1(-/-), and IRS2(-/-) male mice fed a high-fat diet.
    Aoki K; Tajima K; Taguri M; Terauchi Y
    J Steroid Biochem Mol Biol; 2016 May; 159():110-20. PubMed ID: 26976654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Dehydroepiandrosterone (DHEA) on Diabetes Mellitus and Obesity.
    Aoki K; Terauchi Y
    Vitam Horm; 2018; 108():355-365. PubMed ID: 30029734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin signaling in health and disease.
    White MF
    Science; 2003 Dec; 302(5651):1710-1. PubMed ID: 14657487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of Insulin Receptor Substrates (IRS) in renal function and renal hemodynamics.
    Hashimoto S; Maoka T; Kawata T; Mochizuki T; Koike T; Shigematsu T
    PLoS One; 2020; 15(12):e0242332. PubMed ID: 33270683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mathematical model of the impact of insulin secretion dynamics on selective hepatic insulin resistance.
    Zhao G; Wirth D; Schmitz I; Meyer-Hermann M
    Nat Commun; 2017 Nov; 8(1):1362. PubMed ID: 29118381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding.
    Kubota N; Kubota T; Itoh S; Kumagai H; Kozono H; Takamoto I; Mineyama T; Ogata H; Tokuyama K; Ohsugi M; Sasako T; Moroi M; Sugi K; Kakuta S; Iwakura Y; Noda T; Ohnishi S; Nagai R; Tobe K; Terauchi Y; Ueki K; Kadowaki T
    Cell Metab; 2008 Jul; 8(1):49-64. PubMed ID: 18590692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRS2 takes center stage in the development of type 2 diabetes.
    Brady MJ
    J Clin Invest; 2004 Oct; 114(7):886-8. PubMed ID: 15467824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling.
    Guo S; Dunn SL; White MF
    Mol Endocrinol; 2006 Dec; 20(12):3389-99. PubMed ID: 16916938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The function of miRNAs and their potential as therapeutic targets in burn-induced insulin resistance (review).
    Yu Y; Chai J
    Int J Mol Med; 2015 Feb; 35(2):305-10. PubMed ID: 25484249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption.
    Zheng Y; Yamada H; Sakamoto K; Horita S; Kunimi M; Endo Y; Li Y; Tobe K; Terauchi Y; Kadowaki T; Seki G; Fujita T
    J Am Soc Nephrol; 2005 Aug; 16(8):2288-95. PubMed ID: 15975995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased interaction with insulin receptor substrate 1, a novel abnormality in insulin resistance and type 2 diabetes.
    Caruso M; Ma D; Msallaty Z; Lewis M; Seyoum B; Al-janabi W; Diamond M; Abou-Samra AB; Højlund K; Tagett R; Draghici S; Zhang X; Horowitz JF; Yi Z
    Diabetes; 2014 Jun; 63(6):1933-47. PubMed ID: 24584551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.